A mixed evidence set: some compounds have early human trials, others mostly biomarker, mechanistic or observational support.
They map neatly onto hallmarks-of-ageing narratives and can be sold as supplements.
A change in an ageing clock, mitochondrial marker or short functional test is not evidence of longer healthy life.
Appraise each compound separately and show dose, population, comparator, duration and endpoint.